Semin Neurol 2022; 42(04): 479-488
DOI: 10.1055/s-0042-1757927
Review Article

Headache in the Pediatric Population: Focus on Migraine

Samantha L. Irwin
1   Department of Neurology, University of California, San Francisco (UCSF), California
,
Kaitlin A. Greene
2   Division of Pediatric Neurology, Department of Pediatrics, Oregon Health and Science University (OHSU), Portland, Oregon
,
Sara J. Pavitt
3   Department of Neurology, University of Texas, Austin, Texas
,
Alexandra C. Ross
4   Department of Pediatrics, University of California, San Francisco (UCSF), California
› Author Affiliations

Abstract

Pediatric headache is a common condition with significant impact on quality of life and ability to function in academic, social, and extracurricular activities. Most pediatric patients seen in primary care and neurology clinics with headache have primary headache disorders. Diagnosis is largely based on clinical history. Imaging is rarely needed in the absence of red flag features. Careful diagnosis is important to guide appropriate treatment. Treatment focuses on a biopsychosocial model integrating lifestyle, pharmacologic and nonpharmacologic treatment modalities. As few therapies are approved in the pediatric population, treatments are often used off-label based on evidence extrapolated from adult studies. Outcomes vary over time but are generally favorable when headache disorders are diagnosed promptly and managed in a multidisciplinary setting.



Publication History

Article published online:
02 November 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Abu-Arafeh I, Razak S, Sivaraman B, Graham C. Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev Med Child Neurol 2010; 52 (12) 1088-1097
  • 2 GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396 (10258): 1204-1222
  • 3 Powers SW, Patton SR, Hommel KA, Hershey AD. Quality of life in childhood migraines: clinical impact and comparison to other chronic illnesses. Pediatrics 2003; 112 (1, Pt 1): e1-e5
  • 4 Kernick D, Reinhold D, Campbell JL. Impact of headache on young people in a school population. Br J Gen Pract 2009; 59 (566) 678-681
  • 5 Arruda MA, Bigal ME. Migraine and migraine subtypes in preadolescent children: association with school performance. Neurology 2012; 79 (18) 1881-1888
  • 6 Wakefield EO, Belamkar V, Litt MD, Puhl RM, Zempsky WT. “There's nothing wrong with you”: pain-related stigma in adolescents with chronic pain. J Pediatr Psychol 2022; 47 (04) 456-468
  • 7 Powers SW, Coffey CS, Chamberlin LA. et al; CHAMP Investigators. Trial of amitriptyline, topiramate, and placebo for pediatric migraine. N Engl J Med 2017; 376 (02) 115-124
  • 8 Monastero R, Camarda C, Pipia C, Camarda R. Prognosis of migraine headaches in adolescents: a 10-year follow-up study. Neurology 2006; 67 (08) 1353-1356
  • 9 Dooley JM, Augustine HF, Brna PM, Digby AM. The prognosis of pediatric headaches – a 30-year follow-up study. Pediatr Neurol 2014; 51 (01) 85-87
  • 10 Bille B. A 40-year follow-up of school children with migraine. Cephalalgia 1997; 17 (04) 488-491 , discussion 487
  • 11 U.S. Department of Education. Office for Civil Rights, Free Appropriate Public Education for Students With Disabilities: Requirements Under Section 504 of the Rehabilitation Act of 1973, Washington, DC; 2010
  • 12 Karvounides D, Marzouk M, Ross AC. et al. The intersection of COVID-19, school, and headaches: problems and solutions. Headache 2021; 61 (01) 190-201
  • 13 Wöber C, Brannath W, Schmidt K. et al; PAMINA Study Group. Prospective analysis of factors related to migraine attacks: the PAMINA study. Cephalalgia 2007; 27 (04) 304-314
  • 14 Lateef TM, Merikangas KR, He J. et al. Headache in a national sample of American children: prevalence and comorbidity. J Child Neurol 2009; 24 (05) 536-543
  • 15 Torres-Ferrus M, Vila-Sala C, Quintana M. et al. Headache, comorbidities and lifestyle in an adolescent population (the TEENs study). Cephalalgia 2019; 39 (01) 91-99
  • 16 Lipton RB, Manack A, Ricci JA, Chee E, Turkel CC, Winner P. Prevalence and burden of chronic migraine in adolescents: results of the chronic daily headache in adolescents study (C-dAS). Headache 2011; 51 (05) 693-706
  • 17 Victor TW, Hu X, Campbell JC, Buse DC, Lipton RB. Migraine prevalence by age and sex in the United States: a life-span study. Cephalalgia 2010; 30 (09) 1065-1072
  • 18 Kernick D, Stapley S, Campbell J, Hamilton W. What happens to new-onset headache in children that present to primary care? A case-cohort study using electronic primary care records. Cephalalgia 2009; 29 (12) 1311-1316
  • 19 Costa FM, Ferreira IP, Mascarenhas IF, Alves CF, Bento VA, Loureiro HC. Diagnosis and treatment of headache in a pediatric emergency department. Pediatr Emerg Care 2020; 36 (12) 571-574
  • 20 Conicella E, Raucci U, Vanacore N. et al. The child with headache in a pediatric emergency department. Headache 2008; 48 (07) 1005-1011
  • 21 Kan L, Nagelberg J, Maytal J. Headaches in a pediatric emergency department: etiology, imaging, and treatment. Headache 2000; 40 (01) 25-29
  • 22 Burton LJ, Quinn B, Pratt-Cheney JL, Pourani M. Headache etiology in a pediatric emergency department. Pediatr Emerg Care 1997; 13 (01) 1-4
  • 23 Schankin CJ, Straube A, Bassetti CL, Fischer U. Headache in the emergency department. [article in German]. Nervenarzt 2017; 88 (06) 597-606
  • 24 Papetti L, Capuano A, Tarantino S, Vigevano F, Valeriani M. Headache as an emergency in children and adolescents. Curr Pain Headache Rep 2015; 19 (03) 3
  • 25 Lewis DW, Qureshi F. Acute headache in children and adolescents presenting to the emergency department. Headache 2000; 40 (03) 200-203
  • 26 Scagni P, Pagliero R. Headache in an Italian pediatric emergency department. J Headache Pain 2008; 9 (02) 83-87
  • 27 Anttila P, Metsähonkala L, Aromaa M. et al. Determinants of tension-type headache in children. Cephalalgia 2002; 22 (05) 401-408
  • 28 Antonaci F, Voiticovschi-Iosob C, Di Stefano AL, Galli F, Ozge A, Balottin U. The evolution of headache from childhood to adulthood: a review of the literature. J Headache Pain 2014; 15 (01) 15
  • 29 Ekbom K, Ahlborg B, Schéle R. Prevalence of migraine and cluster headache in Swedish men of 18. Headache 1978; 18 (01) 9-19
  • 30 Wang SJ, Fuh JL, Lu SR, Juang KD. Chronic daily headache in adolescents: prevalence, impact, and medication overuse. Neurology 2006; 66 (02) 193-197
  • 31 Hershey AD, Powers SW, Bentti AL, LeCates S, deGrauw TJ. Characterization of chronic daily headaches in children in a multidisciplinary headache center. Neurology 2001; 56 (08) 1032-1037
  • 32 Bigal ME, Lipton RB, Tepper SJ, Rapoport AM, Sheftell FD. Primary chronic daily headache and its subtypes in adolescents and adults. Neurology 2004; 63 (05) 843-847
  • 33 Alfonzo M, Chen L. Acute migraine management in children. Pediatr Emerg Care 2015; 31 (10) 722-727 , quiz 728–730
  • 34 Tsze DS, Ochs JB, Gonzalez AE, Dayan PS. Red flag findings in children with headaches: prevalence and association with emergency department neuroimaging. Cephalalgia 2019; 39 (02) 185-196
  • 35 Raucci U, Della Vecchia N, Ossella C. et al. Management of childhood headache in the emergency department: review of the literature. Front Neurol 2019; 10: 886
  • 36 Raieli V, Eliseo M, Pandolfi E. et al. Recurrent and chronic headaches in children below 6 years of age. J Headache Pain 2005; 6 (03) 135-142
  • 37 Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders. 3rd edition. Cephalalgia 2018; 38 (01) 1-211
  • 38 Kors EE, Haan J, Ferrari MD. Genetics of primary headaches. Curr Opin Neurol 1999; 12 (03) 249-254
  • 39 Wöber-Bingöl C. Epidemiology of migraine and headache in children and adolescents. Curr Pain Headache Rep 2013; 17 (06) 341
  • 40 Hershey AD, Winner PK. Pediatric migraine: recognition and treatment. J Am Osteopath Assoc 2005; 105 (4, Suppl 2): 2S-8S
  • 41 Lambru G, Matharu M. Management of trigeminal autonomic cephalalgias in children and adolescents. Curr Pain Headache Rep 2013; 17 (04) 323
  • 42 Gelfand AA, Gelfand JM, Prabakhar P, Goadsby PJ. Ophthalmoplegic “migraine” or recurrent ophthalmoplegic cranial neuropathy: new cases and a systematic review. J Child Neurol 2012; 27 (06) 759-766
  • 43 Puledda F, Schankin C, Goadsby PJ. Visual snow syndrome: a clinical and phenotypical description of 1,100 cases. Neurology 2020; 94 (06) e564-e574
  • 44 Ahmed M, Canlas J, Mahenthiran M, Al-Ani S. Primary stabbing headache in children and adolescents. Dev Med Child Neurol 2020; 62 (01) 69-74
  • 45 Gelfand AA, Johnson H, Lenaerts ME. et al. Neck-tongue syndrome: a systematic review. Cephalalgia 2018; 38 (02) 374-382
  • 46 D'Amico A, Galati C, Manzo ML, Reina F, Nocera GM, Raieli V. Red ear syndrome in children: review of literature and report of three cases. Int J Pediatr Otorhinolaryngol 2021; 142: 110615
  • 47 Lewis DW, Ashwal S, Dahl G. et al; Quality Standards Subcommittee of the American Academy of Neurology; Practice Committee of the Child Neurology Society. Practice parameter: evaluation of children and adolescents with recurrent headaches: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2002; 59 (04) 490-498
  • 48 Rho YI, Chung HJ, Suh ES. et al. The role of neuroimaging in children and adolescents with recurrent headaches–multicenter study. Headache 2011; 51 (03) 403-408
  • 49 Alexiou GA, Argyropoulou MI. Neuroimaging in childhood headache: a systematic review. Pediatr Radiol 2013; 43 (07) 777-784
  • 50 The Childhood Brain Tumor Consortium. The epidemiology of headache among children with brain tumor. Headache in children with brain tumors. J Neurooncol 1991; 10 (01) 31-46
  • 51 Irwin SL, Gelfand AA. Occipital headaches and neuroimaging in children. Curr Pain Headache Rep 2018; 22 (09) 59
  • 52 Genizi J, Khourieh-Matar A, Assaf N, Chistyakov I, Srugo I. Occipital headaches in children: Are they a red flag?. J Child Neurol 2017; 32 (11) 942-946
  • 53 Oskoui M, Pringsheim T, Holler-Managan Y. et al. Practice guideline update summary: Acute treatment of migraine in children and adolescents: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. [Published correction appears in Neurology. 2020;7;94(1):50] Neurology 2019; 93 (11) 487-499
  • 54 Oskoui M, Pringsheim T, Billinghurst L. et al. Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. [Published correction appears in Neurology. 2020;7;94(1):50] Neurology 2019; 93 (11) 500-509
  • 55 Frattarelli DA, Galinkin JL, Green TP. et al; American Academy of Pediatrics Committee on Drugs. Off-label use of drugs in children. Pediatrics 2014; 133 (03) 563-567
  • 56 Gelfand AA, Irwin SL. Lifestyle advice for pediatric migraine: Blaming the patient, or evidence based?. Semin Neurol 2020; 40 (03) 277-285
  • 57 Robberstad L, Dyb G, Hagen K, Stovner LJ, Holmen TL, Zwart JA. An unfavorable lifestyle and recurrent headaches among adolescents: the HUNT study. Neurology 2010; 75 (08) 712-717
  • 58 Busch V, Gaul C. Exercise in migraine therapy–is there any evidence for efficacy? A critical review. Headache 2008; 48 (06) 890-899
  • 59 Santiago MD, Carvalho DdeS, Gabbai AA, Pinto MM, Moutran AR, Villa TR. Amitriptyline and aerobic exercise or amitriptyline alone in the treatment of chronic migraine: a randomized comparative study. Arq Neuropsiquiatr 2014; 72 (11) 851-855
  • 60 Varkey E, Cider A, Carlsson J, Linde M. Exercise as migraine prophylaxis: a randomized study using relaxation and topiramate as controls. Cephalalgia 2011; 31 (14) 1428-1438
  • 61 Pavkovic IM, Kothare SV. Migraine and sleep in children: a bidirectional relationship. Pediatr Neurol 2020; 109: 20-27
  • 62 Hummer DL, Lee TM. Daily timing of the adolescent sleep phase: Insights from a cross-species comparison. Neurosci Biobehav Rev 2016; 70: 171-181
  • 63 Gelfand AA, Pavitt S, Greene K. et al. High school start time and migraine frequency in high school students. Headache 2019; 59 (07) 1024-1031
  • 64 Adolescent Sleep Working Group; Committee on Adolescence; Council on School Health. School start times for adolescents. Pediatrics 2014; 134 (03) 642-649
  • 65 Bruni O, Galli F, Guidetti V. Sleep hygiene and migraine in children and adolescents. Cephalalgia 1999; 19 (Suppl. 25) 57-59
  • 66 Law EF, Wan Tham S, Aaron RV, Dudeney J, Palermo TM. Hybrid cognitive-behavioral therapy intervention for adolescents with co-occurring migraine and insomnia: a single-arm pilot trial. Headache 2018; 58 (07) 1060-1073
  • 67 Verrotti A, Agostinelli S, D'Egidio C. et al. Impact of a weight loss program on migraine in obese adolescents. Eur J Neurol 2013; 20 (02) 394-397
  • 68 Kenney EL, Long MW, Cradock AL, Gortmaker SL. Prevalence of inadequate hydration among US children and disparities by gender and race/ethnicity: national health and nutrition examination survey, 2009-2012. Am J Public Health 2015; 105 (08) e113-e118
  • 69 Blau JN. Water deprivation: a new migraine precipitant. Headache 2005; 45 (06) 757-759
  • 70 Lantéri-Minet M, Mick G, Allaf B. Early dosing and efficacy of triptans in acute migraine treatment: the TEMPO study. Cephalalgia 2012; 32 (03) 226-235
  • 71 Pascual J. Clinical benefits of early triptan therapy for migraine. Headache 2002; 42 (Suppl. 01) 10-17
  • 72 Hämäläinen ML, Hoppu K, Valkeila E, Santavuori P. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology 1997; 48 (01) 103-107
  • 73 Silberstein SD, Lipton RB, Dodick DW. et al; Topiramate Chronic Migraine Study Group. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 2007; 47 (02) 170-180
  • 74 Dodick DW, Turkel CC, DeGryse RE. et al; PREEMPT Chronic Migraine Study Group. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 2010; 50 (06) 921-936
  • 75 Winner PK, Kabbouche M, Yonker M, Wangsadipura V, Lum A, Brin MF. A randomized trial to evaluate OnabotulinumtoxinA for prevention of headaches in adolescents with chronic migraine. Headache 2020; 60 (03) 564-575
  • 76 MacLennan SC, Wade FM, Forrest KM, Ratanayake PD, Fagan E, Antony J. High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial. J Child Neurol 2008; 23 (11) 1300-1304
  • 77 Talebian A, Soltani B, Banafshe HR, Moosavi GA, Talebian M, Soltani S. Prophylactic effect of riboflavin on pediatric migraine: a randomized, double-blind, placebo-controlled trial. Electron Physician 2018; 10 (02) 6279-6285
  • 78 Thompson DF, Saluja HS. Prophylaxis of migraine headaches with riboflavin: a systematic review. J Clin Pharm Ther 2017; 42 (04) 394-403
  • 79 Wang F, Van Den Eeden SK, Ackerson LM, Salk SE, Reince RH, Elin RJ. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache 2003; 43 (06) 601-610
  • 80 Gallelli L, Avenoso T, Falcone D. et al. Effects of acetaminophen and ibuprofen in children with migraine receiving preventive treatment with magnesium. Headache 2014; 54 (02) 313-324
  • 81 Hershey AD, Powers SW, Vockell AL. et al. Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache 2007; 47 (01) 73-80
  • 82 Slater SK, Nelson TD, Kabbouche MA. et al. A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine. Cephalalgia 2011; 31 (08) 897-905
  • 83 Gelfand AA, Goadsby PJ. The role of melatonin in the treatment of primary headache disorders. Headache 2016; 56 (08) 1257-1266
  • 84 Gonçalves AL, Martini Ferreira A, Ribeiro RT, Zukerman E, Cipolla-Neto J, Peres MF. Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention. J Neurol Neurosurg Psychiatry 2016; 87 (10) 1127-1132
  • 85 Fallah R, Fazelishoroki F, Sekhavat L. A randomized clinical trial comparing the efficacy of melatonin and amitriptyline in migraine prophylaxis of children. Iran J Child Neurol 2018; 12 (01) 47-54
  • 86 Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E. Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. [Published correction appears in Neurology. 2013;26;80(9):871] Neurology 2012; 78 (17) 1337-1345
  • 87 Ailani J, Burch RC, Robbins MS. Board of Directors of the American Headache Society. The American Headache Society Consensus Statement: update on integrating new migraine treatments into clinical practice. Headache 2021; 61 (07) 1021-1039
  • 88 Greene KA, Gentile CP, Szperka CL. et al. Calcitonin gene-related peptide monoclonal antibody use for the preventive treatment of refractory headache disorders in adolescents. Pediatr Neurol 2021; 114: 62-67
  • 89 Szperka CL, VanderPluym J, Orr SL. et al. Recommendations on the use of anti-CGRP monoclonal antibodies in children and adolescents. Headache 2018; 58 (10) 1658-1669
  • 90 Irwin SL, Qubty W, Allen IE, Patniyot I, Goadsby PJ, Gelfand AA. Transcranial magnetic stimulation for migraine prevention in adolescents: a pilot open-label study. Headache 2018; 58 (05) 724-731
  • 91 Hershey AD, Lin T, Gruper Y. et al. Remote electrical neuromodulation for acute treatment of migraine in adolescents. Headache 2021; 61 (02) 310-317
  • 92 Grazzi L, Egeo G, Liebler E, Padovan AM, Barbanti P. Non-invasive vagus nerve stimulation (nVNS) as symptomatic treatment of migraine in young patients: a preliminary safety study. Neurol Sci 2017; 30 (Suppl. 01) 197-199 DOI: 10.1007/s10072-017-2942-5.
  • 93 Kabbouche MA, Gilman DK. Management of migraine in adolescents. Neuropsychiatr Dis Treat 2008; 4 (03) 535-548
  • 94 Dobson D, Dobson KS. Evidence-Based Practice of Cognitive-Behavioral Therapy. Guilford Publications; 2018
  • 95 Trautmann E, Lackschewitz H, Kröner-Herwig B. Psychological treatment of recurrent headache in children and adolescents–a meta-analysis. Cephalalgia 2006; 26 (12) 1411-1426
  • 96 Fisher E, Law E, Dudeney J, Palermo TM, Stewart G, Eccleston C. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev 2018; 9 (09) CD003968
  • 97 Powers SW, Kashikar-Zuck SM, Allen JR. et al. Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial. JAMA 2013; 310 (24) 2622-2630
  • 98 Faedda N, Cerutti R, Verdecchia P, Migliorini D, Arruda M, Guidetti V. Behavioral management of headache in children and adolescents. J Headache Pain 2016; 17 (01) 80
  • 99 Fichtel A, Larsson B. Does relaxation treatment have differential effects on migraine and tension-type headache in adolescents?. Headache 2001; 41 (03) 290-296
  • 100 Holden EW, Deichmann MM, Levy JD. Empirically supported treatments in pediatric psychology: recurrent pediatric headache. J Pediatr Psychol 1999; 24 (02) 91-109
  • 101 Yucha C, Montgomery D. Evidence-Based Practice in Biofeedback and Neurofeedback. Colorado: AAPB; 2008
  • 102 Stubberud A, Varkey E, McCrory DC, Pedersen SA, Linde M. Biofeedback as prophylaxis for pediatric migraine: a meta-analysis. Pediatrics 2016; 138 (02) e20160675
  • 103 Blume HK, Brockman LN, Breuner CC. Biofeedback therapy for pediatric headache: factors associated with response. Headache 2012; 52 (09) 1377-1386
  • 104 Powers SW, Mitchell MJ, Byars KC, Bentti AL, LeCates SL, Hershey AD. A pilot study of one-session biofeedback training in pediatric headache. Neurology 2001; 56 (01) 133
  • 105 Perry-Parrish C, Copeland-Linder N, Webb L, Sibinga EM. Mindfulness-based approaches for children and youth. Curr Probl Pediatr Adolesc Health Care 2016; 46 (06) 172-178
  • 106 Gu Q, Hou JC, Fang XM. Mindfulness meditation for primary headache pain: a meta-analysis. Chin Med J (Engl) 2018; 131 (07) 829-838
  • 107 Ali A, Weiss TR, Dutton A. et al. Mindfulness-based stress reduction for adolescents with functional somatic syndromes: a pilot cohort study. J Pediatr 2017; 183: 184-190
  • 108 Hall A, Brand A, Kedia S. Nonpharmaceutical options for pediatric headache: nutraceuticals, manual therapies, and acupuncture. In: Pediatric Headache. Elsevier; 2022: 223-266
  • 109 Linde K, Allais G, Brinkhaus B. et al. Acupuncture for the prevention of episodic migraine. Cochrane Database Syst Rev 2016; 2016 (06) CD001218
  • 110 Gottschling S, Meyer S, Gribova I. et al. Laser acupuncture in children with headache: a double-blind, randomized, bicenter, placebo-controlled trial. Pain 2008; 137 (02) 405-412
  • 111 Kemper KJ, Sarah R, Silver-Highfield E, Xiarhos E, Barnes L, Berde C. On pins and needles? Pediatric pain patients' experience with acupuncture. Pediatrics 2000; 105 (4, Pt 2): 941-947